Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study

BACKGROUND: Many countries are experiencing a resurgence of COVID-19, driven predominantly by the delta (B.1.617.2) variant of SARS-CoV-2. In response, these countries are considering the administration of a third dose of mRNA COVID-19 vaccine as a booster dose to address potential waning immunity o...

Descripción completa

Detalles Bibliográficos
Autores principales: Barda, Noam, Dagan, Noa, Cohen, Cyrille, Hernán, Miguel A, Lipsitch, Marc, Kohane, Isaac S, Reis, Ben Y, Balicer, Ran D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555967/
https://www.ncbi.nlm.nih.gov/pubmed/34756184
http://dx.doi.org/10.1016/S0140-6736(21)02249-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555967/
https://www.ncbi.nlm.nih.gov/pubmed/34756184
http://dx.doi.org/10.1016/S0140-6736(21)02249-2

Ejemplares similares